Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Director/PDMR Shareholding

20th Jan 2010 07:00

RNS Number : 8008F
Acta S.p.A.
20 January 2010
 



20 January 2010 

Acta S.p.A.

Director/PDMR Shareholding

Acta S.p.A (the "Company") announces today that, following the recommendation of the Remuneration Committee, on 19 January 2009 the Board approved the following grants of options over the Ordinary Shares of the Company to the Directors pursuant to the 2010 Share Option Scheme (the "Options"). The grant of the Options is conditional upon approval by the shareholders at the Shareholders' Meeting.

The table below states the number of Options granted to the Directors under the 2010 Option Scheme, together with the total number of options available to each Director following the grant of Options.

Name

Title

Number of Options granted

Total options held following grant

Paolo Bert

Chief Executive Officer

509,024

2,168,788

Paul Barritt

Chief Financial Officer

303,990

777,653

Robert Drummond

Non-Executive Chairman

96,885

261,657

Fabio Mastrangelo

Non-Executive Director

83,045

206,486

Marco Casoni

Non-Executive Director

69,203

186,925

Details of the 2010 Share Option Scheme are as follows:

The exercise price of the Options is 15.0p per share, representing a premium of 7% over the closing mid-market price of 14.0p on 18 January 2010. The Options will vest two years after the date of their approval at the Shareholders' Meetingand may be exercised within four years of vesting.

Other conditions of vesting, exercise and expiry of the Options are as determined by the Share Option Scheme Rules approved by the shareholders on 5 September 2007.

- Ends -

For further information please contact:

Acta S.p.A

Paul Barritt, Chief Financial Officer

Tel: +39 050 644281

Charles Stanley Securities

Tel: +44 (0)20 7149 6000

Nominated Adviser

Russell Cook / Freddy Crossley 

Notes to Editors

About Acta 

Acta develops and manufactures clean technology products and unique patented catalysts which have been launched to the renewable energy, automotive, battery and industrial markets. Acta is also developing other commercial opportunities using its catalysts for industrial waste treatment.

Acta's catalysts and alkaline system know-how are at the heart of the Company's development of a new, high pressure water electrolyser technology which has demonstrated low cost, platinum free, high pressure hydrogen generation. Combined with a platinum free fuel cell, the system offers a solution to the problem of how to store surplus energy produced from large scale, intermittent renewable energy sources (eg wind farms). In addition, the low cost, small size and simplicity of the hydrogen generator makes it ideally suited as a recharger of commercial fuel cell applications (fuel cell bikes, electrical generators, UPS systems, etc).

Acta's catalysts are also undergoing customer tests in applications such as ammonia treatment (removal of ammonia from an industrial waste stream), and zinc-air batteries (a high performance and environmentally friendly battery technology), as well as fuel cell and other applications.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSMMGMMVLMGGZM

Related Shares:

ACTA.L
FTSE 100 Latest
Value8,809.74
Change53.53